Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia
Nature Medicine2016Vol. 23(1), pp. 69–78
Citations Over TimeTop 1% of 2016 papers
Stefanie Göllner, Thomas Oellerich, Shuchi Agrawal‐Singh, Tino Schenk, Hans‐Ulrich Klein, Christian Rohde, Caroline Pabst, Tim Sauer, Mads Lerdrup, Sigal Tavor, Friedrich Stölzel, Sylvia Herold, Gerhard Ehninger, Gabriele Köhler, Kuan‐Ting Pan, Henning Urlaub, Hubert Serve, Martin Dugas, Karsten Spiekermann, Binje Vick, Irmela Jeremias, Wolfgang E. Berdel, Klaus Hansen, Arthur Zelent, Claudia Wickenhauser, Lutz Müller, Christian Thiede, Carsten Müller‐Tidow
Related Papers
- → Bortezomib-Induced Skin Eruption(2008)17 cited
- → Bortezomib-induced Pneumonitis During Bortezomib Retreatment in Multiple Myeloma(2012)11 cited
- → The clinical potential of proteasome inhibition(2004)1 cited
- → Abstract C32: Gene expression analysis of myeloma cells resistant and sensitive to bortezomib.(2011)
- → [Effects of bortezomib combined with 5-azacytidine on the apoptosis of K562 cells and expression of SHIP mRNA].(2014)